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GhanaAims: The current study was designed to document medicinal plant species that are
traditionally used to treat tuberculosis (TB) by Ghanaian communities.
Methods: The medicinal plants used against TB or its signs and symptoms were selected
using library and online published data searches. A guided questionnaire interview was
also conducted with a botanist involved in plant collection at the Centre for Scientific
Research into Plant Medicine (CSRPM) at Mampong. Data obtained were entered in Excel
and summarized into means and frequencies using SPSS 12.0.1 for windows, and
expressed as tables and bar graphs.
Results: A total of 15 medicinal plant species distributed between 13 genera and 13 families
were documented. The following medicinal plant species were found to be used against TB
in Greater Accra and Eastern parts of Ghana: Azadirachta indica A. Juss. Stem bark (Meli-
aceae), Hygrophila auriculata Heine, whole plant (Acanthaceae), Chenopodium ambrosioides
L. leaves (Amaranthaceae), Coix lacryma-jobi L. glumes (Poaceae), Solanum torvum Sw. unripe
fruits (Solanaceae), Solanum torvum Sw. leaves (Solanaceae), Bidens pilosa L. whole plant
(Asteraceae), Phyllanthus fraternus G.L. Webster leaves (Phyllanthaceae), Dissotis rotundifolia
(Sm.) Triana, leaves (Melastomataceae), Cymbopogon giganteus Chiov. Leaves (Poaceae),
Cyperus articulatus L. roots (Cyperaceae), Allium sativum L. bulb (Amaryllidaceae), Zingiber
officinale Roscoe, rhizomes (Zingiberaceae), Allium cepa L. bulbs (Amaryllidaceae), Allium
cepa L. leaves (Amaryllidaceae), Aloe vera var. barbadensis aqueous extract from leaves
(Xanthorrhoeaceae), Aloe vera var. barbadensis organic extract from leaves (Xanthor-
rhoeaceae), Cocos nucifera Linn, water (Arecaceae) and Cocos nucifera Linn. Husk (Arecaceae).
Conclusions: The collected plant species could be a source of a new class of drugs against
TB. Bioactivity guided fractionation is recommended to identify lead compounds for
antimycobacterial activity. The current paper documents for the first time medicinal plant
species used by Ghanaian communities to treat TB. These results are a basis for selection of
plants for further pharmacological, toxicological and phytochemical studies in developing
new plant-based antimycobacterial drugs.
 2015 Asian African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
All rights reserved.of Ghana,
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Tuberculosis (TB) is a major public health concern with over
2 billion people currently infected, 8.6 million new cases per
year, and more than 1.3 million deaths annually [1]. The cur-
rent drug regimen combination for TB consists of isoniazid,
rifampicin, ethambutol and pyrazinamide, administered over
six months [2,3]. Although this treatment has a high success
rate, the utility of this regimen is limited by compliance
issues, which has resulted in the rise of strains that are resis-
tant to some or all of the first- and second-line antibiotics [4].
These strains, called multidrug resistant (MDR), extensively
drug resistant (XDR) and totally drug resistant (TDR) strains
of Mycobacterium tuberculosis (M. tb), have worse disease out-
comes [5]. Widespread introduction of antibiotics in the
1940s, beginning with penicillin [6–8] and streptomycin [9]
transformed medicine, providing effective cures for the most
prevalent diseases of the time. Resistance development limits
the useful lifespan of antibiotics and results in the require-
ment of a constant introduction of new compounds [10].
However, antimicrobial drug discovery is uniquely difficult
[11], primarily due to poor penetration of compounds into
bacterial cells. Recent efforts in TB drug development have
resulted in the discovery of new therapeutics, including dela-
manid (previously known as OPC 67683) and bedaquiline (pre-
viously known as TMC 207), which retain activity against MDR
and XDRM. tb strains. However, additional drugs are urgently
needed. Natural products and their plant-derived analogs are
often a source of drugs or drug templates with limited toxi-
city, which has the potential to mitigate compliance issues
during protracted administration. Plant-based drugs have
been used worldwide in traditional medicines for the treat-
ment of various diseases and Ghana is no exception.
Approximately 60% of the world’s population still relies on
medicinal plants for their primary healthcare. According to
a survey by the National Cancer Institute (NCI), United
States of America (USA), 61% of the 877 small-molecule new
chemical entities introduced as drugs worldwide during the
period 1981–2002 were inspired by natural product research
[12]. Plant species still serve as a rich source of many novel
biologically active compounds, yet very few plant species
have been thoroughly investigated for their medicinal proper-
ties [13], and thus, there is renewed interest in phytomedicine
research.
TB is a huge public health problem in Ghana [14]. It is esti-
mated that approximately 20,000 people contracted TB in
Ghana in 2011, of which around 22% were not detected
and/or reported [13,14]. According to 2011 data from the
World Health Organization (WHO), 14,962 cases of TB were
reported, comprising an incidence of 79 cases per 100,000.
Of these, 18 cases per 100,000 corresponded to co-infection
with Human Immunodeficiency Virus-Tuberculosis (HIV-TB)
co-infection [15]. The Ghanaian population still suffers the
problems typical of an underdeveloped, tropical country,
with clear and markedly high death rates resulting from
malnutrition, tropical infectious diseases, and low vaccine
coverage. In Ghana, it is estimated that around 70% ofhealthcare is provided by traditional healers using medicinal
plants. There is an estimated one traditional healer for every
400 inhabitants, and one physician with conventional
medical training for every 6200 (in Accra, the capital city)
to 42,200 inhabitants in the rural areas [16]. To achieve global
control of this epidemic, there is an urgent need for new TB
drugs which can: (1) shorten treatment duration; (2)
target MDR or XDR strains; (3) simplify treatment by reducing
the daily pill burden; (4) lower dosing frequency (for
example, a once-weekly regimen); and (5) be co-administered
with HIV medications [17]. The current study was thus
designed to document medicinal plant species traditionally
used by the Greater Accra and Eastern communities of
Ghana to treat TB.
Materials and methods
Library and online published data searches
A library search was carried out on medicinal plant species
used in traditional medicine to treat TB. In particular,
plants cited in the book ‘‘African traditional medicine: a
dictionary of plant use and applications’’ [18] and growing
in Ghana were selected, verified if they already had been
identified at the Herbarium of the Centre for Scientific
Research into Plant Medicine (CSRPM), Mampong, and
assigned a voucher number as a specimen collection of
the CSRPM, with the help of the CSRPM botanist team,
led by Mr. Ofori Lartey. Plant species were collected from
the Greater Accra and Eastern regions of Ghana as shown
in Fig. 1.
Guided questionnaire interview
A guided questionnaire interview was also administered to
the botanist at CSRPM. The interview elicited information
on plant species used in the traditional treatment of TB. All
species obtained from literature and those mentioned during
the interview were collected during July and December 2014
and are indexed as MN (Mwanzia Nguta). The specimenswere
identified by the staff of CSRPM and named according to the
Flora of West Tropical Africa in accordance with the interna-
tional code for botanical nomenclature. The specimens were
deposited at the CSRPM. Data obtained were entered in
Excel and summarized into means and frequencies using
SPSS 12.0.1 for windows, and expressed as tables and bar
graphs. Ethical approval for this study was granted by the
Scientific and Technical Committee of Noguchi Memorial
Institute for Medical Research (STC-NMIMR), project identifi-
cation number EC/060/08. Before interviewing the botanist
at CSRPM, the objectives of the study, method and planned
use of the information were explained, and permission to
conduct the interview was sought. Verbal consent was
obtained in all cases before the interview was carried out.
Selected plants used against TB were also checked if they
were published elsewhere in Africa, apart from the work of
Neuwinger [18].
Fig. 1 – Map of Ghana. Source: www.mapsofworld.com.
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Greater Accra and Eastern communities of Ghana was also
sought after from the online and library search. The interview
conducted with the botanist at CSRPM also generated infor-
mation in regard to the methods used traditionally to extract
the active constituents from the anti-TB medicinal plant
species.Results
Medicinal plant species used by the Greater Accra and Eastern
communities to treat TB
The global problem presented by the rise in multidrug-resis-
tant strains of TB has necessitated research for new sources
Table 1 – Plant species collected from Ghana based on literature reports on their use as anti-tb plants.
Plant species Voucher specimen Number Family Plant part
Azadirachta indica A. Juss. MND14/7 Meliaceae Stem bark
Hygrophila auriculata Heine. MNS14/7 Acanthaceae Whole plant
Chenopodium ambrosioides L. MNA14/7 Amaranthaceae Leaves
Coix lacryma-jobi L. MNO-K24/7 Poaceae Glumes
Solanum torvum Sw. MNB-N(A)24/7 Solanaceae Unripe fruits
Solanum torvum Sw. MNBL-N(A)24/7 Solanaceae Leaves
Bidens pilosa L. MNM24/7 Asteraceae Whole plant
Phyllanthus fraternus G.L. Webster MNM20/7 Phyllanthaceae Leaves
Dissotis rotundifolia (Sm.) Triana MNM22/7 Melastomataceae Leaves
Cymbopogon giganteus Chiov. MNM21/7 Poaceae Leaves
Cyperus articulatus L. MNB31/7 Cyperaceae Roots
Allium sativum L. MNK31/7 Amaryllidaceae Bulbs
Zingiber officinale Roscoe MNK24/7 Zingiberaceae Rhizomes
Allium cepa L. MNKB14/7 Amaryllidaceae Bulbs
Allium cepa L. MNKL14/7 Amaryllidaceae Leaves
Aloe vera var. barbadensis MNMA26/11 Xanthorrhoeaceae Leaves (aqueous extract)
Aloe vera var. barbadensis MNM026/11 Xanthorrhoeaceae Leaves (Organic extract)
Cocos nucifera Linn. MNKW14/12 Arecaceae Coconut water
Cocos nucifera Linn. MNKH14/12 Arecaceae Husk
Fig. 2 – Families with plant species used against
tuberculosis.
Fig. 3 – Plant part used to treat tuberculosis.
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designed to document antimycobacterial plants traditionally
used by Ghanaian communities to treat TB. A total of 15 plant
species distributed between 13 genera and 13 families were
documented as illustrated in Table 1. The documented
medicinal plants were: Azadirachta indica A. Juss. Stem bark
(Meliaceae); Hygrophila auriculata Heine. whole plant
(Acanthaceae); Chenopodium ambrosioides L. leaves
(Amaranthaceae); Coix lacryma-jobi L. glumes (Poaceae);
Solanum torvum Sw. unripe fruits (Solanaceae); S. torvum Sw.
leaves (Solanaceae); Bidens pilosa L. whole plant (Asteraceae);
Phyllanthus fraternus G.L. Webster leaves (Phyllanthaceae);
Dissotis rotundifolia (Sm.) Triana leaves (Melastomataceae);
Cymbopogon giganteus Chiov. Leaves (Poaceae); Cyperus artic-
ulatus L. roots (Cyperaceae); Allium sativum L. bulb
(Amaryllidaceae); Zingiber officinale Roscoe rhizomes
(Zingiberaceae); Allium cepa L. bulbs (Amaryllidaceae); A. cepa
L. leaves (Amaryllidaceae); Aloe vera var. barbadensis leaves
(Xanthorrhoeaceae); Cocos nucifera Linn. Water (Arecaceae)
and C. nucifera Linn. husk (Arecaceae).
Different families produced varying numbers of anti-TB
plant species, with the highest number of medicinal plants
documented belonging to the Amaryllidaceae family as
demonstrated in Fig. 2.
Leaves were reported to be the most commonly used plant
to treat TB as shown in Fig. 3 below.
The local Ghanaian communities use water mainly to pre-
pare anti-TB treatments from the listed plant parts as decoc-
tions or infusions. These extraction methods have been
utilized since time immemorial, and to the best of their
knowledge, they yield active principles required to treat TB.
The studied plant species have been shown to possess activ-
ity against the slow growing pathogenic strain of M. tb as
shown in Table 2 below. This observation further validates
the ethnomedical use of the studied ethnobotanicals in tradi-
tional medicine to treat conditions with signs and symptoms
that closely resemble TB. These reports clearly indicate thatGhanaian communities can be trusted with their knowledge,
and the documented medicinal plants are a potential source
of a new class of drugs against TB.
Discussion
TB remains a major global health problem [19]. It causes ill-
health among millions of people each year and ranks as the
second leading cause of death from an infectious disease
Table 2 – Literature reports on pharmacological and phytochemical properties of documented anti-tb plants.
Plant species Family Pharmacological activity reported Reported phytochemical constituents
Azadirachta indica A. Juss. Meliaceae Activity against S. aureus; E. coli and
K. pneumoniae [22], M. smegmatis
and M. aurum [23]
Flavonoids, tannins [22]
Hygrophila auriculata Heine. Acanthaceae No reports Saponins, alkaloids, steroids, tannins, flavonoids and
triterpenoids [23,31]
Chenopodium ambrosioides L. Amaranthaceae Activity against MDR strains of M. tb [32] Phenolics, flavonoids, saponins, ecdysteroids and
triterpenoids [32]
Coix lacryma-jobi L. Poaceae Antimutagenic activity [34] p-Hydroxybenzaldehyde, vanillin, syringaldehyde,
trans-coniferylaldehyde, sinapaldehyde, and coixol
[34]
Solanum torvum Sw. (unripe fruits) Solanaceae Activity against M. tb H37Rv [26] Sterols, tannins, saponins, flavonoids, glycosides [33]
Solanum torvum Sw. (leaves) Solanaceae Activity against M. tb H37Rv [26] Sterols, tannins, saponins, flavonoids, glycosides [33]
Bidens pilosa L. Asteraceae Activity against drug sensitive M. tb [27] Chalcone glucosides [35]
Phyllanthus fraternus G.L. Webster Phyllanthaceae No reported activity Alkaloids, tannins, saponins, terpenoids and steroids
[36]
Dissotis rotundifolia (Sm.) Triana Melastomataceae No reported activity C-glycosyl-flavones, orientin, vitexin, isovitexin [37]
Cymbopogon giganteus Chiov. Poaceae No reported activity Acyclic alcohol (1-hentriacontanol), three triterpenes
(sistosterol, stigmasterol and methoxyparkeol) and a
dipeptide (N-benzoylphenylalanine-
Nbenzoylphenylalanilate) [38]
Cyperus articulatus L. Cyperaceae Anti-Onchocerca activity [39] Terpenoids, hydrocarbons and fatty acids [39]
Allium sativum L. Amaryllidaceae Active against M. tb MDR strains and H37Rv [21] Alkaloids, flavonoids, cardiac glycosides, terpenes,
resin [40]
Zingiber officinale Roscoe Zingiberaceae Antimicrobial activity [29] Monoterpenoids, sesquiterpenoids, phenols [29]
Allium cepa L. (bulb) Amaryllidaceae Active against M. tb MDR strains and H37Rv [21] Alkaloids, flavonoids, cardiac glycosides, terpenes,
resin [40]
Allium cepa L. (leaves) Amaryllidaceae Active against M. tb MDR strains and H37Rv [21] Alkaloids, flavonoids, cardiac glycosides, terpenes,
resin [40].
Aloe vera var. barbadensis
(organic extract)
Xanthorrhoeaceae Active against M. tb MDR strains and H37Rv [21];
Active against S. pyogenes and P. aeroginosa[42]
Tannins, saponins, flavonoids, terpenoids [42]
Aloe vera var. barbadensis
(aqueous extract)
Xanthorrhoeaceae Active against M. tb MDR strains and H37Rv [21];
S. pyogenes and P. aeroginosa [42]
Tannins, saponins, flavonoids, terpenoids [42]
Cocos nucifera Linn. (water) Arecaceae Anticancer activity [41] Phytohormones (cytokinins, auxin, gibberellins,
abscisic acid, salicylic acid) [41]
Cocos nucifera Linn. (husk) Arecaceae Selective activity against S. aureus [30] Catechin, epicatechin, tannins [30]
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used are derived from natural products or have depended
upon a natural product for their development, and the recent
discoveries of the antimalarial artemisinin and the anticancer
agent taxol indicate the continuing importance of plant spe-
cies in drug discovery. However, only a small proportion of
plant species have been thoroughly investigated for their
medicinal properties [19] and undoubtedly there are many
novel biologically active compounds yet to be discovered.
The current study was designed to document antimy-
cobacterial plant species used by the Greater Accra and
Eastern communities of Ghana. A database of medicinal
plants used to treat TB by Ghanaian communities was gener-
ated. To the best of the present research’s knowledge, the cur-
rent paper reports for the first time medicinal plant species
used in Ghana to treat TB. This repository of selected anti-TB
plants can be used in future studies aimed at high throughput
screening for antimycobacterial activity using fast-growing
laboratory strains of Mycobacterium smegmatis. Such studies
may lead to the isolation of active ligands against sensitive,
latent and drug-resistant strains of M. tb. A total of 15 plant
species belonging to 13 genera and distributed in 13 families
as summarized in Table 1 were documented. The majority of
these species belonged to the families Amaryllidaceae (3),
Xanthorrhoeaceae (2), Arecaceae (2), Poaceae (2) and
Solanaceae (2) as indicated in Table 1. A diverse group of
phytochemical compounds and pharmacological activities
have been associated with the documented plant species as
reported in Table 2, supporting their ethnopharmacological
use against TB by the Ghanaian communities.
The use of some of the documented antituberculous
plants is supported by earlier observations of antimy-
cobacterial activity [21] against MDR strains and laboratory
reference strain H37Rv while screening aqueous extracts of
A. sativum, A. cepa and Aloe vera using Lowenstein–Jensen
medium and Middlebroook 7H9 broth. The observed antimy-
cobacterial activity validates the ethnopharmacological uti-
lization of the medicinal species to treat TB, and calls upon
further investigation to isolate the phytochemical compounds
responsible for the reported activity. Methanolic and ethano-
lic crude extracts obtained from A. indica have been reported
to possess potent activity against Escherichia coli, K. pneumonia
and methicillin resistant S. aureus [22], while moderate activ-
ity frommethanolic leaf extracts against M. smegmatis andM.
aurum has been reported [23]. The observed biological activi-
ties, especially those against mycobacterial species, adds
more weight to the ethnobotanical reports in regard to the
use of A. indica crude extracts against TB, justifying why more
studies are required to isolate and purify the active con-
stituents responsible for the reported activity. This observa-
tion further validates the ethnobotanical usage of the
documented plants against TB by Ghanaian communities.
The utilization of leaves from H. auriculata as antituberculous
agents has been reported in Uganda, East Africa [24]. This
cross-cultural acceptance and use of the same plant species
in different geographical zones is an indication of the poten-
tial of the plant species as a future source of a new class of
drugs against TB. The documentation of the plant species in
Uganda supports the Ghanaian traditional claims in regard
to the antituberculous activity of H. auriculata, calling formore studies aimed at isolating and characterizing the
phytochemicals responsible for the reported anecdotal effi-
cacy of the said plant. Antimicrobial activity from the ace-
tonic leaf extracts obtained from Chenopodium ambrosoides
against MDR strains ofM. tb has been reported [25], validating
the ethnopharmacological use of the plant among Ghanaian
communities and the inclusion of the plant in Ghanaian phar-
macopoeia as a potential source of anti-TB drugs. This obser-
vation adds more weight to the documentation of the said
plant in regard to its traditional use against TB. Moderate
inhibition of the pathogenic laboratory reference strain
H37Rv by hydromethanolic fruit extracts from S. torvum has
been observed [26] in Malaysia, validating the
ethnopharmacological use of the unripe fruits against TB by
the Ghanaian communities. This observation is in agreement
with this documented report and supports further studies in
search for anti-TB drugs from Ghanaian pharmacopoeia.
The use of the plant in different continents throws more
weight into the antimycobacterial potential of the docu-
mented plant, calling for more resources to disclose the active
ligands behind the reported observation. The leaves of B.
pilosa from Rwanda have been reported to possess activity
against M. tb [27] further validating the use of this plant in
Ghanaian ethnotherapy and this subsequent documentation
of the said plant for further investigations in search of an
agent against TB. Scientists from Kwazulu Natal have
reported C. articulatus to be used traditionally against cough
and related upper respiratory tract conditions [28], supporting
the traditional use of the plant against TB in Ghana. The use
of the plant for related illnesses in different countries further
validates its ethnopharmacological utilization and positions
it as a possible source of future agents against TB. Ginger (Z.
officinale) extract (10 mg/kg) administered intraperitoneally
has been shown to possess a dose-dependent antimicrobial
activity against Pseudomonas aeruginosa, Salmonella typhimur-
ium, E. coli and Candida albicans. In addition, out of 29 plant
extracts screened, ginger extract was found to have the
broadest range of anti-fungal activity measured either by
the fungi inhibited or as the average diameter of the zones
of inhibition and was the only crude extract that was active
against Rhizopus sp., an organism that was not inhibited by
any of the other plant extracts tested or by the anti-fungal
agent ketoconazole or berberine [29]. Based on these findings,
it is plausible to argue out that the crude extract could be
efficacious against M. tb, underpinning its traditional use by
the Ghanaian communities to treat TB. This calls for evalua-
tion of the antimycobacterial activity of Z. officinale crude
extracts using M. tb specific assays. Selective antimicrobial
activity against S. aureus has been observed while evaluating
C. nucifera for antimicrobial activity [30]. Since this plant
enjoys diverse medicinal uses [30], other activities, including
antimycobacterial activity, may be identified using different
biological assays. C. nucifera may be important in the identifi-
cation of some novel agents against drug-resistant strains of
M. tb. The majority of the plants documented in this study
were collected from community land, which is facing great
pressure due to overutilization of indigenous trees and hence
medicinal plants may disappear before their uses are docu-
mented. Most of the inhabitants of Greater Accra and
Eastern regions of Ghana are in the low social-economic
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affordable treatment option. Medicinal plant use will there-
fore remain an integral part of the health care system to the
community for a long time to come. Consequently, ethnob-
otanical exploration should not only be a cost-effective
means of locating new and useful tropical plant compounds
against TB, but also be linked to the urgent need for sustain-
able conservation strategies for medicinal plants, since
human expansionist demands can be expected to cause
environmental deterioration and biotic destruction well into
the next century.
Conclusions
The documented medicinal plant species used by the
Ghanaian communities are a potential source of a new class
of antituberculous drugs. The current study recommends
bioactivity guided isolation and purification of lead com-
pounds for antimycobacterial activity from the selected plant
species. Many plant species reported in this study have been
investigated for their phytoconstituents and pharmacological
activities, the latter being in agreement with ethnomedical
uses associated with the documented species in Ghana. Nine
plant species documented in the current study have not been
investigated for their antimycobacterial activity. In Ghana, tra-
ditional methods of treatments based on medicinal plants are
still an important part of social life and culture, and the
acceptability of these plants as claimed effective remedies is
quite high among the population of this area. The claimed
therapeutic value of the reported species call for modern
scientific studies to establish their safety and efficacy and to
preserve and document this florawhichmay otherwise be lost
due to erosion of age-old traditional methods of biodiversity
conservation andmedicinal knowledge [43]. There is a general
consensus that traditional knowledge on the use of medicinal
plants must be conserved because of its vital role for human
well-being. It is often argued that if traditional knowledge
which has been generated over a long period of time is lost,
exploitation of plants among other things will become diffi-
cult, if not impossible. Among the reasons traditional knowl-
edge is considered reliable for the exploitation of herbal
remedies is that indigenous communities through a period
of long experimentation with herbal medicines are likely to
have retained those that are effective and tolerably safe while
discarding preparationswith low efficacy or acute toxicity [44].
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